(19)
(11) EP 4 051 256 A1

(12)

(43) Date of publication:
07.09.2022 Bulletin 2022/36

(21) Application number: 20793412.6

(22) Date of filing: 27.10.2020
(51) International Patent Classification (IPC): 
A61K 31/192(2006.01)
A61P 11/12(2006.01)
A61K 9/00(2006.01)
 A61K 31/198(2006.01)
A61P 11/14(2006.01)
A61K 9/16(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/192; A61K 31/198; A61P 11/12; A61P 11/14; A61K 9/1652; A61K 9/1623; A61K 9/0056; A61K 9/0095; A61K 9/1611
 
C-Sets:
  1. A61K 31/192, A61K 2300/00;
  2. A61K 31/198, A61K 2300/00;
(86) International application number:
PCT/EP2020/080135
(87) International publication number:
WO 2021/083867 (06.05.2021 Gazette 2021/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 28.10.2019 IT 201900019858

(71) Applicant: E-Pharma Trento S.p.A.
38123 Trento (IT)

(72) Inventors:
  • BOSCHETTI, Silvia
    38060 Aldeno (TN) (IT)
  • BENVENUTI, Claudio
    20154 Milano (IT)

(74) Representative: PGA S.p.A. 
Via Mascheroni, 31
20145 Milano
20145 Milano (IT)

   


(54) PHARMACEUTICAL COMPOSITION INCLUDING A SYNERGISTIC COMBINATION OF IBUPROFEN AND N-ACETYLCYSTEINE